Neuromodulation in epilepsy: state-of-the-art approved therapies
Ryvlin P, Rheims S, Hirsch LJ, Sokolov A, Jehi L
The Lancet Neurology · 2021
Key finding
Until then, neuromodulation could be considered for individuals with intractable seizures, ideally after the possibility of curative surgical treatment has been carefully assessed and ruled out or judged less appropriate.
Auto-extracted · verification pendingHow we verify
- Condition
- Epilepsy
- Stimulation
- iVNS
- Evidence tier
- Narrative / Scoping Review
- Participants
- —
Share this study
Download the citation card as a PNG, or copy a link to this page.
Cite this study
Ryvlin, P., Rheims, S., Hirsch, L. J., Sokolov, A., & Jehi, L. (2021). Neuromodulation in epilepsy: state-of-the-art approved therapies. The Lancet Neurology, 20(12), 1038-1047. https://doi.org/10.1016/S1474-4422(21)00300-8
Related studies in Epilepsy
Can transcutaneous auricular vagus nerve stimulation be considered a viable adjuntive therapy in drug-resistant epilepsy? A systematic review and meta-analysis of randomized controlled trials
Moro et al. · Epilepsy & behavior : E&B · 2025 · Systematic Review / Meta-Analysis
The effect of Vagus nerve stimulation (VNS) on seizure control, cognitive function, and quality of life in individuals with drug-resistant epilepsy: A systematic review article
Melese et al. · Epilepsia open · 2024 · Systematic Review / Meta-Analysis
Effects of vagus nerve stimulation on cognitive function in patients with epilepsy: a systematic review and meta-analysis
Kong et al. · Frontiers in neurology · 2024 · Systematic Review / Meta-Analysis
Transcutaneous auricular vagus nerve stimulation for epilepsy
Zhang et al. · Seizure · 2024 · Systematic Review / Meta-Analysis
Summary by Vagus Research. Always consult the primary source for the authoritative record.